CDC vs VYM
VictoryShares US EQ Income Enhanced Volatility Wtd ETF vs Vanguard High Dividend Yield ETF
Which is better, CDC or VYM?
Each has led over a different period.
VYM has a lower expense ratio. CDC led over 1Y, VYM over 3Y, 5Y and the full window. CDC is less concentrated, with 14.8% of the fund in its ten largest positions against 26.1%.
MarketXLS is not an investment adviser. This comparison is generated automatically from market data and is for information only. A Best mark means the better reading on that one measure, not a recommendation to buy.
Side-by-Side Comparison
| Metric | CDC | VYM |
|---|---|---|
| Expense Ratio | 0.35% | 0.04%Best |
| AUM | $738M | $81.6B |
| Dividend Yield | 3.05% | 2.22% |
| Holdings | 102 | 613 |
| YTD Return | +15.00%Best | +12.29% |
| 1Y Return | +17.28%Best | +16.61% |
| 3Y Return (annualized) | +13.82% | +17.42%Best |
| 5Y Return (annualized) | +6.41% | +12.12%Best |
| Volatility (annualized) | 12.4%Best | 13.7% |
| Max Drawdown | -21.4%Best | -35.7% |
| $10,000 over 5 years | $13,643 | $17,718Best |
| Top 10 Weight | 14.8%Best | 26.1% |
| Fund Family | Victory Capital Management Inc. | Vanguard (US) |
| Category | Equity | Equity |
| Style | Large Cap Value | Large Cap Value |
| Inception | Jul 1, 2014 | Nov 10, 2006 |
Volatility and max drawdown are measured over the window both funds cover: Jul 2, 2014 to Sep 17, 2026 (12.2 years).
CDC vs VYM growth
Month-end closes. Both lines start at 0% in the first month shown, so the gap between them is the difference in growth across that window. The full view covers the 12.2 years both funds cover.
CDC vs VYM Performance
VictoryShares US EQ Income Enhanced Volatility Wtd ETF (CDC) is an ETF from Victory Capital Management Inc. and Vanguard High Dividend Yield ETF (VYM) is an ETF from Vanguard (US). Over the past year CDC returned +17.28% while VYM returned +16.61%. Year to date, CDC is up 15.00% versus a gain of 12.29% for VYM.
Over three years, CDC compounded at +13.82% per year against +17.42% for VYM; over five years the annualized figures are +6.41% and +12.12% respectively. Across the full 12-year window we track, VYM has the edge at +8.89% annualized vs +8.14%.
Past performance does not guarantee future results.
Risk: Volatility and Drawdowns
VYM has been the more volatile fund, with annualized monthly volatility of 13.7% compared with 12.4% for CDC. Lower volatility generally means a smoother ride, though it often comes with lower long-run returns.
The deepest peak-to-trough decline in our data was -21.4% for CDC and -35.7% for VYM. Drawdown depth is what each fund did in the worst stretch of the window measured above.
The two funds' monthly returns correlate at 0.88. They usually move together, but the gap leaves some room for diversification.
Fees and Cost Over Time
CDC charges 0.35% per year while VYM charges 0.04%. On a $10,000 position that is $35 vs $4 annually, a gap of $31 per year that compounds over a long holding period. On income, CDC currently yields 3.05% against 2.22% for VYM.
Holdings Overlap
96.6% of CDC's money is in holdings VYM also owns. 35.2% of VYM's money is in holdings CDC also owns.
Most of CDC is already inside VYM. Owning both mostly buys the same companies twice.
96 positions in common, counted across the 101 positions we hold weights for in CDC and 557 in VYM, against full books of 102 and 613.
What only one of them owns
Our book lists 434 positions for VYM that do not appear in our book for CDC (62.0% of the fund), and 4 for CDC that do not appear in VYM (2.5%).
Some of those will be the same company recorded under a different code in one of the two books, so the real difference in what you would own is no larger than this and may be smaller. We do not name the individual positions here for that reason.
Top Shared Holdings
| Stock | Weight in CDC | Weight in VYM | Difference |
|---|---|---|---|
| XOMExxon Mobil Corp. | 1.12% | 2.63% | 1.51% |
| KOCoca Cola Co. | 1.58% | 1.38% | 0.20% |
| ABBVAbbvie Inc. | 1.06% | 1.80% | 0.74% |
| CVXChevron Corp | 1.28% | 1.48% | 0.20% |
| PGProcter & Gamble Company | 1.20% | 1.37% | 0.17% |
| MRKMerck & Company Inc | 1.02% | 1.31% | 0.29% |
| UNHUnitedhealth Group Incorporated | 0.73% | 1.52% | 0.79% |
| HDHome Depot Inc/The | 0.88% | 1.34% | 0.46% |
| PMPhilip Morris International Inc. | 0.93% | 1.21% | 0.28% |
| DUKDuke Energy Corp | 1.53% | 0.40% | 1.13% |
96.6% of CDC is already inside VYM.
You probably hold more than these two. Add the rest and see how much of the whole book is the same companies twice.
Free for up to 10 holdings. No account needed.
Frequently Asked Questions
Which is cheaper, CDC or VYM?
CDC has an expense ratio of 0.35% while VYM charges 0.04%. VYM is the cheaper option, by $31 a year on a $10,000 investment.
Which performed better, CDC or VYM?
Over the past year CDC returned +17.28% vs +16.61% for VYM, so CDC leads on 1-year performance. Over the longest common window we track (12 years), CDC annualized +8.14% vs +8.89% for VYM. Past performance does not guarantee future results. This is information, not a recommendation.
Which is riskier, CDC or VYM?
VYM has been the more volatile fund at 13.7% annualized versus 12.4% for CDC. Worst drawdown: CDC -21.4% vs VYM -35.7%.
Should I hold both CDC and VYM?
CDC and VYM have a monthly-return correlation of 0.88, so their returns are far enough apart for the mix to behave differently from either one alone. This is information, not a recommendation.
What is the holdings overlap between CDC and VYM?
96.6% of CDC's money is in holdings VYM also owns. 35.2% of VYM's is in holdings CDC also owns. They hold 96 positions in common, counted across the 101 positions we hold weights for in CDC and 557 in VYM.
Which pays a higher dividend, CDC or VYM?
CDC yields 3.05% while VYM yields 2.22%, so CDC currently pays the higher dividend yield.
Is VYM better than CDC?
VYM has a lower expense ratio. CDC led over 1Y, VYM over 3Y, 5Y and the full window. CDC is less concentrated, with 14.8% of the fund in its ten largest positions against 26.1%. Which one suits a particular account depends on what it is for. This is information, not a recommendation.